Rachel Church, Ph.D.
UNC Eshelman School of Pharmacy, 3311 Kerr Hall, CB# 7569, Chapel Hill, NC, 27599-7569
Rachel Church, Ph.D., researches ways to broaden the use and understanding of newer biomarkers by leading the UNC Organ Injury Biomarker Core. The goal of this core is to assist investigators in all aspects of research studies in which injury to the liver, kidney, and/or heart is suspected. For more information, please visit the Core website.
Multiple factors, including exposure to xenobiotics, sepsis, and ischemia, can precipitate instances of organ injury; however, the current biomarkers routinely utilized to detect these injuries, both in nonclinical and clinical settings, are suboptimal. Traditional biomarkers lack the specificity and/or sensitivity necessary for early identification of organ injury. Newer biomarkers have not only demonstrated enhanced sensitivity and specificity for the detection of organ injury but can additionally offer the advantage of providing mechanistic insight.
Church is also interested in identifying novel biomarkers of organ injury and identifying novel methods for utilizing traditional biomarkers.
- 2017 Junior Faculty Development Award